会计年度:2007-12-31收入分布
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 出口贸易 | 21,570,225.62 | 17,777,179.48 | -- | -- |
| 胶囊 | 525,303,101.80 | 137,967,565.60 | 387,335,536.20 | 73.74 |
| 颗粒剂、冲剂 | 5,883,145.00 | 4,365,618.97 | 1,517,526.03 | 25.79 |
| 口服液 | 32,428,546.34 | 10,811,560.05 | 21,616,986.29 | 66.66 |
| 片丸剂 | 18,415,476.05 | 13,421,952.38 | 4,993,523.67 | 27.12 |
| 医药工业 | 704,708,581.09 | 178,815,155.10 | -- | -- |
| 医药商业 | 267,841,333.69 | 235,954,377.53 | -- | -- |
| 注射液 | 67,647,405.78 | 20,329,041.29 | 47,318,364.49 | 69.95 |
|
会计年度:2007-06-30
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 出口贸易 | 13,459,550.44 | 11,671,614.10 | -- | -- |
| 胶囊 | 229,569,317.29 | 62,802,788.44 | 166,766,528.85 | 72.64 |
| 颗粒剂、冲剂 | 3,033,390.64 | 2,166,415.66 | 866,974.98 | 28.58 |
| 口服液 | 14,439,741.95 | 4,945,273.18 | 9,494,468.77 | 65.75 |
| 片丸剂 | 9,311,626.25 | 5,791,382.30 | 3,520,243.95 | 37.80 |
| 医药工业 | 277,067,664.53 | 81,228,672.49 | -- | -- |
| 医药商业 | 174,543,570.08 | 129,440,565.92 | -- | -- |
| 注射液 | 20,713,588.40 | 5,522,812.91 | 15,190,775.49 | 73.34 |
|
会计年度:2006-12-31
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 出口贸易 | 20,673,664.71 | 18,674,010.90 | 1,999,653.81 | 9.67 |
| 技术服务 | 3,698,000.00 | -- | 3,698,000.00 | 100.00 |
| 减：抵销 | 74,211,091.61 | 74,211,091.61 | -- | -- |
| 胶囊 | 525,004,997.84 | 101,504,648.13 | 423,500,349.71 | 80.67 |
| 颗粒剂、冲剂 | 6,764,676.13 | 4,964,769.27 | 1,799,906.86 | 26.61 |
| 口服液 | 33,363,097.77 | 11,987,854.34 | 21,375,243.43 | 64.07 |
| 片丸剂 | 13,756,321.46 | 7,690,168.51 | 6,066,152.95 | 44.10 |
| 医药工业 | 536,525,812.50 | 130,457,086.84 | 406,068,725.66 | 75.68 |
| 医药商业 | 366,013,241.18 | 274,818,300.12 | 91,194,941.06 | 24.92 |
| 注射液 | 13,755,761.71 | 3,588,395.27 | 10,167,366.44 | 73.91 |
|
会计年度:2006-06-30
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 出口贸易 | 8,941,559.90 | 8,432,196.12 | 509,363.78 | 5.70 |
| 技术服务 | 1,973,000.00 | -- | 1,973,000.00 | 100.00 |
| 减：抵销 | 45,460,880.91 | 45,460,880.91 | -- | -- |
| 医药工业 | 259,551,808.98 | 64,980,258.07 | 194,571,550.91 | 74.96 |
| 医药商业 | 210,323,687.87 | 161,786,636.50 | 48,537,051.37 | 23.08 |
|
会计年度:2005-12-31
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 出口贸易 | 9,649,328.44 | 9,166,928.57 | 482,399.87 | 5.00 |
| 技术服务 | 3,196,800.00 | -- | -- | -- |
| 减：抵销 | 85,673,283.73 | 85,673,283.73 | -- | -- |
| 医药工业 | 495,290,543.59 | 114,869,871.56 | 380,420,672.03 | 76.81 |
| 医药商业 | 379,955,841.76 | 313,395,882.82 | 66,559,958.94 | 17.52 |
|
6/8 转到 
